GlassScriptPhysician profile
Ashley Mischke
NPI 1518512904
$1,919.29
in general payments reported to CMS, 2019-2025
12 companies · $31.12 in 2025
The $31.12 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $409 · 2023: $960 · 2024: $242 · 2025: $31.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $693.57 | 2021-2023 | Menopur |
| Axonics, INC. | $435.22 | 2023 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $225.69 | 2023-2024 | Gemtesa |
| Emd Serono, INC. | $182.08 | 2023 | |
| Abbvie INC. | $164.07 | 2021-2025 | |
| Astellas Pharma US INC | $113.56 | 2023-2024 | Myrbetriq |
| Boston Scientific Corporation | $24.15 | 2024 | |
| Pfizer INC. | $19.23 | 2023 | |
| Duchesnay USA Incorporated | $16.89 | 2023 | Osphena |
| Novo Nordisk INC | $15.14 | 2021 | |
| Myovant Sciences INC. | $15.05 | 2021 | |
| Laborie Medical Technologies Corp. | $14.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mischke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.